ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Spectrum Pharmaceuticals, Inc.
NEW YORK, April 25, 2023 /PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) and its board of directors concerning the proposed acquisition of the company by Assertio Holdings, Inc. (NASDAQ: ASRT). Stockholders will receive 0.1783 shares of Assertio Holdings common stock and a contingent value right up to $0.20 for each share of Spectrum Pharmaceuticals stock that they hold. The transaction is expected to close in the third quarter of 2023.
If you are a stockholder of Spectrum Pharmaceuticals, Inc. and are interested in obtaining additional information regarding this investigation, please visit us at: http://www.rowleylawpllc.com/investigation/sppi/. You may also contact Shane Rowley, Esq. at Rowley Law PLLC, 50 Main Street Suite 1000, White Plains, NY 10606, by email at [email protected], or by telephone at 914-400-1920 or 844-400-4643 (toll-free).
Rowley Law PLLC represents shareholders nationwide in class actions and derivative lawsuits in complex corporate litigation. For more information about the firm and its attorneys, please visit http://www.rowleylawpllc.com.
Attorney Advertising. Prior results do not guarantee a similar outcome.
SOURCE Rowley Law PLLC
![](https://rt.prnewswire.com/rt.gif?NewsItemId=NY81266&Transmission_Id=202304251837PR_NEWS_USPR_____NY81266&DateId=20230425)
Share this article